These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3073760

  • 1. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
    Becker K, Braquet P, Förster W.
    Biomed Biochim Acta; 1988; 47(10-11):S165-8. PubMed ID: 3073760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N, Etienne A, Braquet P.
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [Abstract] [Full Text] [Related]

  • 5. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P.
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
    [No Abstract] [Full Text] [Related]

  • 6. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
    Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB.
    Eur J Pharmacol; 1986 Aug 07; 127(1-2):83-95. PubMed ID: 3019727
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
    Rola-Pleszczynski M, Pignol B, Pouliot C, Braquet P.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):754-60. PubMed ID: 3493773
    [Abstract] [Full Text] [Related]

  • 8. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
    Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Thromb Res; 1987 Feb 15; 45(4):299-309. PubMed ID: 3576518
    [Abstract] [Full Text] [Related]

  • 9. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
    Berti F, Omini C, Rossoni G, Braquet P.
    Pharmacol Res Commun; 1986 Sep 15; 18(9):775-93. PubMed ID: 3099317
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A, Hecquet F, Guilmard C, Soulard C, Braquet P.
    Int J Tissue React; 1987 Sep 15; 9(1):19-26. PubMed ID: 3596954
    [Abstract] [Full Text] [Related]

  • 11. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
    Etienne A, Hecquet F, Soulard C, Spinnewyn B, Clostre F, Braquet P.
    Agents Actions; 1986 Jan 15; 17(3-4):368-70. PubMed ID: 3515870
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2749-52. PubMed ID: 2820421
    [Abstract] [Full Text] [Related]

  • 13. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
    Baranes J, Hellegouarch A, Le Hegarat M, Viossat I, Auguet M, Chabrier PE, Braquet P.
    Pharmacol Res Commun; 1986 Aug 01; 18(8):717-37. PubMed ID: 3763677
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
    Harczy M, Maclouf J, Pradelles P, Braquet P, Borgeat P, Sirois P.
    Pharmacol Res Commun; 1986 Aug 01; 18 Suppl():111-7. PubMed ID: 3095849
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H, Plantavid M, Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Biochem Biophys Res Commun; 1985 Oct 30; 132(2):460-6. PubMed ID: 2998370
    [Abstract] [Full Text] [Related]

  • 16. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D, Chignard M, Korth R, Le Couedic JP, Norel X, Spinnewyn B, Braquet P, Benveniste J.
    Eur J Pharmacol; 1986 Apr 16; 123(2):197-205. PubMed ID: 3086108
    [Abstract] [Full Text] [Related]

  • 17. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig.
    Bourgain RH, Maes L, Andries R, Braquet P.
    Prostaglandins; 1986 Jul 16; 32(1):142-4. PubMed ID: 3763943
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
    Touvay C, Etienne A, Braquet P.
    Agents Actions; 1986 Jan 16; 17(3-4):371-2. PubMed ID: 3754380
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A, Bernabeu F, Gómez-Garre D, Ramon y Cajal S, Braquet P, López-Novoa JM.
    J Pharmacol Exp Ther; 1990 Apr 16; 253(1):328-33. PubMed ID: 2329516
    [Abstract] [Full Text] [Related]

  • 20. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
    Touvay C, Vilain B, Etienne A, Sirois P, Borgeat P, Braquet P.
    Immunopharmacology; 1986 Oct 16; 12(2):97-104. PubMed ID: 3021651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.